Great points!! Gerald was very adamant yesterday that LymPro will be the gold standard (the expectations are very high on validation results).
In his own words; he has already moved on from the validation results and what beyond in terms of commercialization going forward. Perhaps there could be a bidding war in place; and may Gerald has given BD first right of refusal (and hence; the two extra weeks to make a final decision).
Absurd. You're stating that a company with the client list and the revenue stream that BD possesses would jeopardize it's crediblity and reputation as a provider of independent assay results for purposes of a.......'shakedown' for a more favorable deal?